Travel Vaccines Market Overview:
Travel Vaccines Market Size was valued at USD 3,290.00 Million in 2022 and is projected to reach USD 7,137.89 Million by 2030, growing at a CAGR of 10.2% during the forecast period. The Travel Vaccines is experiencing significant growth as more people recognize the importance of protecting their health while traveling. The market is driven by factors such as the increasing number of international travellers, growing awareness about travel-related diseases, and government initiatives to promote vaccination.
Travel vaccines are a specialized category of vaccines designed to protect individuals from infectious diseases that may be prevalent in specific travel destinations. These vaccines are administered to individuals who are planning to travel internationally or to regions where there is an increased risk of exposure to certain diseases.
Key Players of the Travel Vaccines Market:
The travel vaccines market is characterized by the presence of several key players who compete to meet the travel vaccines growing demand for travel-related immunizations. The competitive landscape is dynamic and constantly evolving. Here are some of the key elements and players in the competitive landscape:
· GSK plc.
· Sanofi
· Merck & Co. Inc.
· Pfizer Inc.
· Bavarian Nordic
· Emergent
· Seqirus
· Valneva SE
· Abbott
· AstraZeneca
Market Segmentation:
By Composition
· Mono Vaccines
· Combination Vaccines
By Disease Type
· Hepatitis A
· DPT
· Yellow Fever
· Typhoid
· Hepatitis B
· Measles and Mumps
· Rabies
· Meningococcal
· Japanese Encephalitis
· Others
By Traveller Type
· Inbound
· Outbound
Please Visit Here To Get Information About: Travel Vaccines Market Size
Regional Analysis:
The United States and Canada are major contributors to the travel vaccines market in North America. The region has a well-established healthcare system, with a focus on preventive healthcare and travel medicine. High levels of international travel, both for business and leisure purposes, drive the demand for travel vaccines.
China, Japan, India, Australia, and South Korea are key markets for travel vaccines in the Asia-Pacific region. Rising disposable incomes, increasing international travel, and growing awareness of travel-related health risks drive travel vaccines market in this region. The region is diverse, with variations in healthcare systems, vaccination policies, and access to travel clinics.
Contact us:
Consegic Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: [email protected]
Other Related Reports:
About Author
